Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis

OBJECTIVE: Non-alcoholic fatty liver disease is highly prevalent in patients with type 2 diabetes mellitus. Studies on glucagon-like peptide-1 receptor agonists for the treatment of non-alcoholic fatty liver disease have reported promising results. Despite this, there has been limited evidence of it...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Chloe, Lee, Ming Hui, Yaow, Clyve Yu Leon, Chin, Yip Han, Goh, Xin Lei, Ng, Cheng Han, Lim, Amanda Yuan Ling, Muthiah, Mark Dhinesh, Khoo, Chin Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063104/
https://www.ncbi.nlm.nih.gov/pubmed/33897616
http://dx.doi.org/10.3389/fendo.2021.609110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063104/
https://www.ncbi.nlm.nih.gov/pubmed/33897616
http://dx.doi.org/10.3389/fendo.2021.609110

Ejemplares similares